Today: 3 April 2026
First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

New York, January 7, 2026, 18:48 (EST) — After-hours

Shares of First Solar (FSLR) fell 10.3% to $241.11 on Wednesday after Jefferies downgraded the U.S. solar panel maker to “hold” from “buy” and cut its price target to $260 from $269. The brokerage cited “limited booking visibility” for 2026 and said a hoped-for “S232” tailwind — shorthand for potential Section 232 duties that can be imposed after a Commerce Department national-security investigation — could “underwhelm investor expectations,” flagging possible carve-outs for Germany and developers moving ahead of any levies. The stock opened at $254.02 and touched $239.26 at its low; volume was about 6.2 million shares. TipRanks

The downgrade lands after a strong run: First Solar has risen about 28% over the past year, Barron’s reported. The shares closed Tuesday at $268.78, about 6% below a $285.99 52-week high set on Dec. 22, MarketWatch data showed. Barron’s+1

That rally has leaned on the idea that U.S. makers with domestic capacity could hold pricing as imports face tighter scrutiny. For traders, the swing factor is orders: new bookings and cancellations can change revenue expectations quickly.

At its third-quarter update in October, the company reported a contracted backlog of 54.5 gigawatts through 2030 and said it had booked about 2.7 GW since the prior call, according to its earnings presentation. It also said it terminated 6.6 GW of bookings tied to defaults by BP affiliates, lifting total “debookings” — cancellations of future orders — to 6.9 GW. First Solar has said a new 3.7-gigawatt U.S. factory is due to start production at the end of 2026. Q4 Investor Relations+1

Other solar names were mixed. Sunrun fell 5.1% and Canadian Solar dropped 6.3%, while Enphase and SolarEdge were little changed.

But the trade call is a moving target. Any Section 232 action could be delayed, watered down by exemptions, or pulled forward by developers trying to lock in supply — outcomes that can soften the pricing lift bulls expect.

At $241, Jefferies’ $260 target implies about 8% upside, leaving a narrower margin for surprise. Traders will watch for signs that bookings recover and for any fresh guidance on costs and factory output.

U.S. labor and inflation data are next on the calendar: the December jobs report is due Friday at 8:30 a.m. ET and December CPI follows on Jan. 13. First Solar is scheduled to report results on March 3 after the close, according to TipRanks. Traders also have the Federal Reserve’s Jan. 27-28 policy meeting in view. TipRanks

Stock Market Today

  • Corcept Therapeutics (CORT) Shares Show Volatility, Discounted Cash Flow Model Suggests Undervaluation
    April 3, 2026, 3:08 PM EDT. Corcept Therapeutics (CORT) shares have been volatile, with a 10.3% gain over the last week and a 20.4% rise over 30 days. Despite a 46.5% drop in the past year, the stock is up 11.2% year to date and has returned over 85% across 3 and 5 years. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $332.45 per share, compared to the recent price near $42.49, indicating the stock may be undervalued by 87.2%. This DCF model discounts future free cash flows to present value, factoring analyst estimates through 2030. Corcept scores 2 out of 6 on Simply Wall St's valuation checks, reflecting mixed signals amid recent optimism and underlying business reassessment.
Procter & Gamble stock keeps sliding — what investors are watching before earnings
Previous Story

Procter & Gamble stock keeps sliding — what investors are watching before earnings

Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead
Next Story

Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead

Go toTop